FDB to Share Insights on Maximizing the Use of Unique Device Identifiers at UDI Conference 2019

Patrick Lupinetti to Provide Expertise on how the UDI Rule is a
Catalyst to Solve Problems, Promote New Developments, and Create New
Opportunities for the Healthcare Industry

SAN FRANCISCO–(BUSINESS WIRE)–#FDA–FDB (First Databank, Inc.), the leading provider of drug and medical
device knowledge that helps healthcare professionals make precise
decisions, announced today that Patrick Lupinetti, J.D., Senior Vice
President for Legal Services and Medical Device, will participate in a
panel entitled “UDI
Data Enrichment & Innovation: Leveraging UDI to Provide Extended Value”

at the UDI
, June 11-12 in Baltimore, MD. The session will take place
on Tuesday, June 11 from 10:45 a.m.-11:45 a.m. ET.

The need for regularity and consistency in medical device information
has been one of the primary drivers behind the US Food and Drug
Administration’s development of the Unique
Device Identifier (UDI)
, which creates a framework that can be
employed in a wide variety of healthcare applications. Because of the
UDI, those conducting clinical, supply chain, patient safety and
research operations can now easily identify relevant device attributes
to aid decision-making. The session will emphasize that the UDI
initiative must consequently be viewed as much more than a regulatory
requirement, but instead, a key that can unlock additional relevant
product attributes, facilitate recall management, improve EHR
documentation, and simplify inventory management. The presentation will
outline the available opportunities and how they might be achieved with
UDI-based data.

Mr. Lupinetti will be joined by co-panelists Dr. James Tcheng, Professor
of Medicine, Duke University School of Medicine and Dr. Joseph Drozda,
Director of Outcomes Research, Mercy Health. The panelists will share
their insights on the UDI’s role in supply chain processes, safety
issues, point-of-care information delivery, and outcomes analysis, as
well as provide a look into the key factors that will drive greater UDI

The session is ideal for anyone affected by the UDI requirement: medical
device manufacturers whose product data will become more widely
accessible to their customers; health care distributors and group
purchasing organizations that can utilize the UDI for operational
efficiency; hospitals and health care organizations that can leverage
the UDI to benefit from a clinically-integrated supply chain; and for
all health care industry professionals looking to support value-based

Mr. Lupinetti commented: “The pharmaceutical arena has benefitted from
the same sort of opportunities, use cases and potential for added value
due to the availability of standardized national drug codes (NDCs), and
many of the solutions that worked for drugs are now feasible for medical
devices with the development of the UDI. We’re hoping the session will
help identify those solutions and suggest how they might be achieved.”

Attendees may also visit FDB at booth #24 to learn how FDB
™ brings clarity to medical device information to improve
clinical, operational, and financial outcomes.

About First Databank

FDB is the leading provider of drug and medical device knowledge that
helps healthcare professionals make precise decisions. With thousands of
customers worldwide, FDB enables our information system developer
partners to deliver valuable, useful, and differentiated solutions. We
offer more than four decades of experience in transforming medical
knowledge into actionable, targeted, and effective solutions that help
improve patient safety, operational efficiency, and healthcare outcomes.
For a complete look at our solutions and services, please visit www.fdbhealth.com
or follow us on Twitter,
and YouTube.

About Hearst Health

The mission of Hearst Health is to help guide the most important care
moments by delivering vital information into the hands of everyone who
touches a person’s health journey. Each year in the U.S., care guidance
from Hearst Health reaches 85 percent of discharged patients, 205
million insured individuals, 77 million home health visits and 3.2
billion dispensed prescriptions. The Hearst Health network includes FDB
(First Databank), Zynx
, MCG,
(formerly MedHOK-Medical House of Knowledge) and Hearst
Health Ventures
Hearst also holds a minority interest in the precision medicine and
oncology analytics company M2Gen.
Follow Hearst Health on Twitter @HearstHealth
or LinkedIn @Hearst-Health.

©2019 First Databank, Inc. Part of the Hearst Health network.
All trademarks mentioned herein are the properties of their respective


Denise Apcar
First Databank (FDB)

error: Content is protected !!